The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process
Crossref DOI link: https://doi.org/10.1186/s13104-018-3636-7
Published Online: 2018-08-29
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Catchpole, Andrew P.
Fullen, Daniel J.
Noulin, Nicolas
Mann, Alex
Gilbert, Anthony S.
Lambkin-Williams, Rob
Text and Data Mining valid from 2018-08-29
Article History
Received: 8 December 2017
Accepted: 24 July 2018
First Online: 29 August 2018